- Shashank has over 28 years of diverse experience in the Pharmaceutical Industry with a PhD in Pharmaceutics (Pharmacokinetics) and an MBA in Management and Information (MIS) Systems.
- The hallmark of his career is his successful leadership in key scientific areas and strategic initiatives at the frontline of drug discovery and development, analytics, science and technology at several pharmaceutical companies based in US, India, Europe, Japan and Brazil such as Somerset Pharmaceuticals, Aventis, Daiichi Sankyo, Piramal Life Sciences, Otsuka and Trevi.
- He has provided leadership in Drug Development including preclinical, Phase I/II/III, regulatory and lifecycle management. He has also supported more than 10 NDAs and several INDs across various therapeutic areas including CNS, Oncology, Cardiovascular, Anti-Infectives, Asthma/allergy and Devices. He has also worked on complex generics and 505(B2) submissions related to small molecules and peptides.
- Shashank is Founder and President of Dasliph Consulting LLC where he has consulted with several companies across discovery and development.
- Shashank has published over 150 abstracts and manuscripts in various international Journals. He has also written 4 book chapters. He holds adjunct faculty positions at the University of Florida and at the University of Tennessee.